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Available online 3 June 2008Thoracic aortic transection (TAT) occurs as a result of
a significant deceleration injury, commonly as a result of
road traffic accidents. It is rarely isolated in its occurrence
and is often associated with multiple injuries. It has an
extremely high mortality, estimated to be 80%. Many cases
that result in free intra-thoracic rupture die at the scene of
the accident whilst those reaching hospital usually have
a contained leak. Traditionally, open surgical repair via
a left thoracotomy was the procedure of choice, however,
it is associated with a significant operative mortality and
morbidity, particularly paraplegia. The use of a less in-
vasive method of repair, therefore, seems common sense
and advantageous in the management of TAT in the
multiple injured patient. The literature is awash with
retrospective and prospective case series describing the
technical feasibility and early results of stent-graft repair
for TAT. To date there are no published randomised
controlled trials comparing endovascular repair to open
surgery and realistically this is unlikely to ever happen due
to the complexity and the urgency of these cases. In this
issue, Mohan et al, present a further prospective case series
of 16 patients presenting with TAT over a seven year period,
to a teaching hospital in Sydney, Australia. The results
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article highlights the low mortality at thirty days along
with the low complication rate for endovascular repair of
TAT. The authors also display the comparable results for
those cases that were performed by open repair. It is
difficult to make any direct comparisons between these
techniques as the numbers are low and non-randomised.
The authors have highlighted that the number of cases
performed by open repair diminished over the seven year
period whilst those undergoing endovascular repair have
inversely increased. So much so, that the first line,
treatment of choice for those presenting with TAT, is an
endovascular approach. Obviously, adopting this treatment
strategy can be problematic. Cardiac and vascular surgeons
and radiologists need to be in agreement with this treat-
ment strategy and work closely together to implement local
protocols for the management of these patients. To offer
such an emergency service with prompt repair needs the
availability of trained staff and most importantly a consign-
ment stock of on the shelf devices of varying diameters and
lengths. The authors demonstrate clearly the range of sizes
that were required for the cases presented, which is helpful
information for any clinician looking at setting an emer-
gency thoracic EVAR service.
One of the main drawbacks of this technique is that there
is very little long-term published data on its durability.
Follow-up was a limiting factor in this study and the authors
have touched upon one of the main reasons for this, being
non-compliance for long term follow-up by a young cohort of
patients. This continues to occur despite educating thesed by Elsevier Ltd. All rights reserved.
Endovascular Repair for Traumatic Transection 159patients on the necessity of repeated imaging and surveil-
lance. Unfortunately, this is a well recognised issue with
younger patients who require long term surveillance.
This paper shows the change in practice that has occurred
in this centre in the treatment of thoracic aortic transection,which is likely to bemirrored inmany centres over theworld.
In the absence of randomised controlled trials, it is imper-
ative that all cases of endovascular repair of thoracic aortic
transections are entered into a registry and an attempt is
made to monitor these patients in the long-term.
